Market Research Logo

Companion Animal Speciality Drugs Market: Veterinary Clinics Distribution Channel Segment to Dominate the Global Market Through 2027 : Global Industry Analysis and Opportunity Assessment 2017-2027

Companion Animal Speciality Drugs Market: Veterinary Clinics Distribution Channel Segment to Dominate the Global Market Through 2027: Global Industry Analysis and Opportunity Assessment 2017-2027"

The largest segment by distribution channel – the veterinary clinics segment – is the most attractive segment in the global market

The Veterinary Clinics segment is the largest segment by distribution channel, which is estimated to create more than US$ 12 Bn, or more than 40% share of the total market in 2017. The Veterinary Clinics segment is expected to create absolute $ opportunity of more than US$ 640 Mn in 2017 over 2016. By the end of 2027, the Veterinary Clinics segment is projected to reach more than US$ 21 Bn or more than 45% share of the total market, expanding at a CAGR of 5.8% over the forecast period. The Veterinary Clinics distribution channel segment dominated the global companion animal speciality drugs market in terms of revenue in 2016, and the trend is projected to continue throughout the forecast period. Veterinary Clinics is also the most attractive segment, with a market attractiveness index of 1.6 over the forecast period.

Rising obesity in pets is one of the major factors boosting the growth of the Veterinary Clinics segment in the global companion animal speciality drugs market

The growing popularity of veterinarians across the globe as a profession has been contributing to an increase in revenue for the Veterinary Clinics distribution channel segment. This is because most people with pets prefer going to a veterinary clinic to obtain prescription drugs rather than opting for self-selection of over-the-counter medications. Globally, hospitals and clinics represent 80% of the service distribution channel for veterinary drugs. Furthermore, increasing tendency to overfeed pets has been resulting in rising obesity in pets globally. This has been negatively impacting the health of pets, thus making them susceptible to more diseases, hence driving demand in the Veterinary Clinics segment.

With growing urbanisation and increasing spread of isolated family units, humanisation of animals is a trend that is growing increasingly across the globe. Adoption of pets as companions has been increasing worldwide, which is specifically driving the need for medicines, preventive treatments and proper hygiene for companion animals. This particular factor is boosting the development of the Veterinary Clinics segment in the global companion animal speciality drugs market.

Increasing urbanisation and growing affluence levels have been driving the adoption of pets, thus driving the demand for pet healthcare services as well. However, it is interesting to note that with rising urbanisation, there has been increasing prevalence of various diseases such as allergies, lower appetite, reduced energy and behavioural anxieties among small companion animals. This has been driving demand for and growth of the Veterinary Clinics segment in the global companion animal speciality drugs market.

Performance analysis of the Veterinary Clinics segment across key regional companion animal speciality drugs markets

The Veterinary Clinics segment dominated the Western Europe companion animal speciality drugs market by distribution channel in terms of revenue in 2016 and the trend is projected to grow throughout the forecast period. Veterinary Clinics is the most attractive segment in the Western Europe regional market, with a market attractiveness index of 1.9 over the forecast period. The Veterinary Clinics segment is anticipated to register a CAGR of 3.3% in terms of value in the North America companion animal speciality drugs market. In APEJ, revenue from the Veterinary Clinics segment is anticipated to increase at a CAGR of 6.5% over the forecast period to reach a market valuation in excess of US$ 2,300 Mn by 2027. Veterinary Clinics is the most attractive segment in the APEJ companion animal speciality drugs market, with an attractiveness index of 1.4 over the forecast period.


1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Companion Animal Drugs Market Analysis Scenario
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunity
4.4. Global Trends
4.5. PEST Analysis - U.S.
4.6. PEST Analysis - Europe
4.7. Portor's Five Analysis
4.8. Trilateral regulatory harmonization between U.S., EU and Japan on registration of veterinary products
5. Global Companion Animal Drugs Market Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value Forecast By Product Type, 2017–2027
5.4.1. Antibiotics
5.4.2. Anti-inflammatory Drugs
5.4.3. Parasiticides
5.4.4. Heartworm
5.4.5. Behavioral Products
5.4.6. Nutritional Products
5.4.7. Anti-Obesity Drugs
5.4.8. Skin Care Products
5.4.9. Vaccines
5.5. Market Attractiveness By Product Type
6. Global Companion Animal Drugs Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel
6.3. Y-o-Y Growth Projections By Distribution Channel
6.4. Market Value Forecast By Distribution Channel, 2017–2027
6.4.1. Veterinary Hospitals
6.4.2. Veterinary Clinics
6.4.3. Pharmacies and Drug Stores
6.5. Market Attractiveness By Distribution Channel
7. Global Companion Animal Drugs Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Western Europe
7.3.4. Eastern Europe
7.3.5. APEJ
7.3.6. Japan
7.3.7. MEA
7.4. Market Attractiveness By Region
8. North America Companion Animal Drugs Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type, 2017–2027
8.2.1. Antibiotics
8.2.2. Anti-inflammatory Drugs
8.2.3. Parasiticides
8.2.4. Heartworm
8.2.5. Behavioral Products
8.2.6. Nutritional Products
8.2.7. Anti-Obesity Drugs
8.2.8. Skin Care Products
8.2.9. Vaccines
8.3. Market Value Forecast By Distribution Channel, 2017–2027
8.3.1. Veterinary Hospitals
8.3.2. Veterinary Clinics
8.3.3. Pharmacies and Drug Stores
8.4. Market Value Forecast By Country, 2017–2027
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By Distribution Channel
8.5.3. By Country
8.6. Regional Trends
8.7. Drivers and Restraints: Impact Analysis
9. Latin America Companion Animal Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type, 2017–2027
9.2.1. Antibiotics
9.2.2. Anti-inflammatory Drugs
9.2.3. Parasiticides
9.2.4. Heartworm
9.2.5. Behavioral Products
9.2.6. Nutritional Products
9.2.7. Anti-Obesity Drugs
9.2.8. Skin Care Products
9.2.9. Vaccines
9.3. Market Value Forecast By Distribution Channel, 2017–2027
9.3.1. Veterinary Hospitals
9.3.2. Veterinary Clinics
9.3.3. Pharmacies and Drug Stores
9.4. Market Value Forecast By Country, 2017–2027
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.4.4. Rest of Latin America
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Distribution Channel
9.5.3. By Country
9.6. Regional Trends
9.7. Drivers and Restraints: Impact Analysis
10. Western Europe Companion Animal Drugs Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2.Market Value Forecast By Product Type, 2017–2027
10.2.1. Antibiotics
10.2.2. Anti-inflammatory Drugs
10.2.3. Parasiticides
10.2.4. Heartworm
10.2.5. Behavioral Products
10.2.6. Nutritional Products
10.2.7. Anti-Obesity Drugs
10.2.8. Skin Care Products
10.2.9. Vaccines
10.3.Market Value Forecast By Distribution Channel, 2017–2027
10.3.1. Veterinary Hospitals
10.3.2. Veterinary Clinics
10.3.3. Pharmacies and Drug Stores
10.4.Market Value Forecast By Country, 2017–2027
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Nordics
10.4.7. Benelux
10.4.8. Rest of Western Europe
10.5.Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By Distribution Channel
10.5.3. By Country
10.6. Regional Trends
10.7. Drivers and Restraints: Impact Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report